Back
The Duckhorn Portfolio Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
22
NAPA
The Duckhorn Portfolio
Last Price:
7.10
Seasonality Move:
-13.16%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
22
The Duckhorn Portfolio (NAPA)
is a Sell
Is The Duckhorn Portfolio a Buy, Sell or Hold?
- The current The Duckhorn Portfolio [NAPA] share price is $7.10. The Score for NAPA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NAPA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NAPA Stock Price Chart
What is The Duckhorn Portfolio's stock price today?
-
The The Duckhorn Portfolio share price today is $7.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAPA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
NAPA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 32.98 | Sell |
Chaikin Money Flow: | 1242281 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.26 - 7.94) | Sell |
Bollinger Bands (100): | (7.76 - 9.16) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.91 | Buy |
Relative Strength Index (14 RSI): | 86.77 | Buy |
Chaikin Money Flow: | -1210062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.8 - 205.74) | Buy |
Bollinger Bands (100): | (136.44 - 176.64) | Buy |
NAPA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.24 | Sell |
20-day SMA: | 7.51 | Sell |
50-day SMA: | 7.87 | Sell |
200-day SMA: | 9.27 | Sell |
8-day EMA: | 7.21 | Sell |
20-day EMA: | 7.46 | Sell |
50-day EMA: | 7.86 | Sell |
200-day EMA: | 9.45 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.44 | Buy |
20-day SMA: | 176.25 | Buy |
50-day SMA: | 159.62 | Buy |
200-day SMA: | 165.96 | Buy |
8-day EMA: | 218.01 | Buy |
20-day EMA: | 188.75 | Buy |
50-day EMA: | 168.9 | Buy |
200-day EMA: | 168.09 | Buy |
The Duckhorn Portfolio Earnings Growth & NAPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.07 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
The Duckhorn Portfolio Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |